NCT05683184View on ClinicalTrials.gov

OMAR Opioid Use Disorder

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions
Healthy ControlOpioid Use Disorder
Interventions
DRUG

[11C]OMAR

For each \[11C\]OMAR PET scan, up to 20 mCi of \[11C\]OMAR will be administered.

Trial Locations (1)

06519

RECRUITING

Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER